This brand name is authorized in Poland
The drug DORITRI contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Benzalkonium chloride
UNII F5UM2KM3W7 - BENZALKONIUM CHLORIDE
|
|
|
|
2
Benzocaine
UNII U3RSY48JW5 - BENZOCAINE
|
|
Benzocaine is a local anaesthetic of the ester type, acting to produce reversible loss of sensation by preventing or diminishing the generation and transmission of sensory nerve impulses near the site of application. Depolarisation of the neuronal membrane and ion exchange are reversibly inhibited. |
|
3
Tyrothricin
UNII 877376V2XW - TYROTHRICIN
|
|
Tyrothricin is a circular polypeptide with antibiotic and bacteriostatic activity. It is effective against gram-positive bacteria. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| R02AA20 | Various | R Respiratory system → R02 Throat preparations → R02A Throat preparations → R02AA Antiseptics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100425110 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
